Economic TimesUPDATE 1-Novartis closes heart drug study early after strong resultsReuters… ». * Study shows drug delays death, reduces hospitalisation. * Novartis to seek approval with global regulators. * Boost after recent Serelaxin setbacks. * Shares rise 1.9 pct, outperform sector (Adds analysts, shares, details). By Caroline Copley. ZURICH …Novartis Says Final-Phase Study on Heart Drug Was SuccessfulBusinessweekSTOCKS NEWS EUROPE-Novartis jumps on positive heart failure drug dataReuters UKNovartis Heart Failure Pill Trial Ends Early on Positive ResultWall Street Journalswissinfo.ch -Economic Times -MarketWatchall 12 news articles …Read Full Story
UPDATE 1-Novartis closes heart drug study early after strong results - Reuters
Real Estate of Cebu
